openPR Logo
Press release

Tinea Pedis Market Outlook 2032: FDA Approvals, Clinical Trials, Epidemiology, Market Size, Therapies, Companies, and Growth Analysis by DelveInsight

06-18-2024 07:20 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Tinea Pedis Market

Tinea Pedis Market

(Albany, USA) DelveInsight's "Tinea Pedis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Tinea Pedis, historical and forecasted epidemiology as well as the Tinea Pedis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Tinea Pedis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Tinea Pedis Market Forecast
https://www.delveinsight.com/sample-request/tinea-pedis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key facts of the Tinea Pedis Market Report:
• The Tinea Pedis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In June 2022, Kerasal has introduced a novel product line for Athlete's Foot, incorporating a distinctive formula offering 5-in-1 benefits. This product aims to effectively address and heal most cases of athlete's foot (tinea pedis), enhance the appearance of the skin, and promote a proactive footcare regimen.
• In May 2022, Bayer's Consumer Health division has introduced an enhanced line of Canesten, their antifungal treatment solution, in India. The product is now available in both powder and cream formats, providing antifungal properties effective for preventing and treating skin infections, including tinea pedis.
• According to information from Omics, the occurrence of any valve disease in Japan is reported at 1.5%. Among individuals with fungal disease, approximately 1.0% are affected by Athlete's foot. Additionally, the prevalence of moderate or severe aortic stenosis in individuals aged over 75 is documented at 2.0%.
• Key Tinea Pedis Companies: Taro Pharmaceutical, South End Skin Care, DermBiont, Inc., Medicis Global Service Corporation, Tinea Pharmaceuticals, Therapeutics, Inc., Novan, Inc. Gilberto De Nucci, Novum Pharmaceuticals, Merz North America, Inc., Padagis LLC, Novartis, Almirall, S.A., DPT Laboratories, Ltd., DermBiont, Inc., Viamet, Bayer, Bausch Health Americas, and others
• Key Tinea Pedis Therapies: TA103, Experimental Drug SESC 01, DBI-001, 33525, Luliconazole, UHE-103A1, SB208, Dapaconazole, Ktoconazole Cream, NAFT-600, Terbinafine, LAS41003, Econazole Nitrate Cream, 1%, Ciclopirox Olamine Cream: J. Lividum, VT-1161, Bifonazole spray, Omeprazole, and others
• The Tinea Pedis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Tinea Pedis pipeline products will significantly revolutionize the Tinea Pedis market dynamics.

Tinea Pedis Overview
Tinea pedis, commonly known as athlete's foot, is a fungal infection of the skin on the feet, typically caused by dermatophytes, a group of fungi that thrive in warm, moist environments. This condition frequently affects athletes and individuals who wear tight-fitting shoes, promoting an ideal environment for fungal growth. The infection is characterized by itching, burning, and cracking of the skin, often between the toes, and can spread to the soles and sides of the feet.
The condition can be classified into four main types: interdigital, moccasin, vesicular, and ulcerative. Interdigital tinea pedis is the most common form, presenting with itching and scaling between the toes. Moccasin type affects the soles, leading to dry, thickened, and scaly skin. Vesicular tinea pedis is less common, involving blister formation on the foot. Ulcerative tinea pedis is severe, with painful ulcers and secondary bacterial infections.
Tinea Pedis Treatment typically involves antifungal medications, either topical (such as creams and powders) or oral for more severe cases. Preventive measures include maintaining good foot hygiene, keeping feet dry, and wearing breathable footwear. Regularly changing socks and avoiding walking barefoot in communal areas can also reduce the risk of contracting the infection. With proper treatment and care, tinea pedis can be effectively managed and prevented.

Get a Free sample for the Tinea Pedis Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/tinea-pedis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Tinea Pedis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Tinea Pedis Epidemiology Segmentation:
The Tinea Pedis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Tinea Pedis
• Prevalent Cases of Tinea Pedis by severity
• Gender-specific Prevalence of Tinea Pedis
• Diagnosed Cases of Episodic and Chronic Tinea Pedis

Download the report to understand which factors are driving Tinea Pedis epidemiology trends @ Tinea Pedis Epidemiology Forecast - https://www.delveinsight.com/sample-request/tinea-pedis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Tinea Pedis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Tinea Pedis market or expected to get launched during the study period. The analysis covers Tinea Pedis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Tinea Pedis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Tinea Pedis Therapies and Key Companies
• TA103: Taro Pharmaceutical
• Experimental Drug SESC 01: South End Skin Care
• DBI-001: DermBiont, Inc.
• 33525: Medicis Global Service Corporation
• Luliconazole: Tinea Pharmaceuticals
• UHE-103A1: Therapeutics, Inc.
• SB208: Novan, Inc.
• Dapaconazole: Gilberto De Nucci
• Ktoconazole Cream: Novum Pharmaceuticals
• NAFT-600: Merz North America, Inc.
• Terbinafine: Novartis
• LAS41003: Almirall, S.A.
• Econazole Nitrate Cream, 1%: DPT Laboratories, Ltd.
• Ciclopirox Olamine Cream: Padagis LLC
• J. Lividum: DermBiont, Inc.
• VT-1161: Viamet
• Bifonazole spray: Bayer
• Omeprazole: Bausch Health Americas

Discover more about therapies set to grab major Tinea Pedis market share @ Tinea Pedis Treatment Landscape
https://www.delveinsight.com/sample-request/tinea-pedis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Tinea Pedis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Tinea Pedis Companies: Taro Pharmaceutical, South End Skin Care, DermBiont, Inc., Medicis Global Service Corporation, Tinea Pharmaceuticals, Therapeutics, Inc., Novan, Inc. Gilberto De Nucci, Novum Pharmaceuticals, Merz North America, Inc., Padagis LLC, Novartis, Almirall, S.A., DPT Laboratories, Ltd., DermBiont, Inc., Viamet, Bayer, Bausch Health Americas, and others
• Key Tinea Pedis Therapies: TA103, Experimental Drug SESC 01, DBI-001, 33525, Luliconazole, UHE-103A1, SB208, Dapaconazole, Ktoconazole Cream, NAFT-600, Terbinafine, LAS41003, Econazole Nitrate Cream, 1%, Ciclopirox Olamine Cream: J. Lividum, VT-1161, Bifonazole spray, Omeprazole, and others
• Tinea Pedis Therapeutic Assessment: Tinea Pedis current marketed and Tinea Pedis emerging therapies
• Tinea Pedis Market Dynamics: Tinea Pedis market drivers and Tinea Pedis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Tinea Pedis Unmet Needs, KOL's views, Analyst's views, Tinea Pedis Market Access and Reimbursement

To know more about Tinea Pedis companies working in the treatment market, visit @ Tinea Pedis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/tinea-pedis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Tinea Pedis Market Report Introduction
2. Executive Summary for Tinea Pedis
3. SWOT analysis of Tinea Pedis
4. Tinea Pedis Patient Share (%) Overview at a Glance
5. Tinea Pedis Market Overview at a Glance
6. Tinea Pedis Disease Background and Overview
7. Tinea Pedis Epidemiology and Patient Population
8. Country-Specific Patient Population of Tinea Pedis
9. Tinea Pedis Current Treatment and Medical Practices
10. Tinea Pedis Unmet Needs
11. Tinea Pedis Emerging Therapies
12. Tinea Pedis Market Outlook
13. Country-Wise Tinea Pedis Market Analysis (2019-2032)
14. Tinea Pedis Market Access and Reimbursement of Therapies
15. Tinea Pedis Market Drivers
16. Tinea Pedis Market Barriers
17. Tinea Pedis Appendix
18. Tinea Pedis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Trending Reports:
• Vascular Access Devices Market: https://www.delveinsight.com/report-store/vascular-access-device-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Alopecia Areata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Ambulatory Arrhythmia Monitoring Devices Market: https://www.delveinsight.com/report-store/ambulatory-arrhythmia-monitoring-devices-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Alopecia Aerata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Urolithiasis Market: https://www.delveinsight.com/report-store/urolithiasis-management-devices-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/growth-hormone-deficiency-ghd-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Choroidal Neovascularization Market: https://www.delveinsight.com/report-store/choroidal-neovascularization-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Ashermans Syndrome Market: https://www.delveinsight.com/report-store/ashermans-syndrome-market
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Dermal Erythema Market: https://www.delveinsight.com/report-store/dermal-erythema-market
• Hiatal Hernia Market: https://www.delveinsight.com/report-store/hiatal-hernia-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tinea Pedis Market Outlook 2032: FDA Approvals, Clinical Trials, Epidemiology, Market Size, Therapies, Companies, and Growth Analysis by DelveInsight here

News-ID: 3542321 • Views:

More Releases from DelveInsight Business Research

Vitiligo Treatment Market 2034: FDA Approvals, Clinical trials, Therapies, Prevalence and Companies by DelveInsight | Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotech
Vitiligo Treatment Market 2034: FDA Approvals, Clinical trials, Therapies, Preva …
(Albany, USA) DelveInsight's "Vitiligo Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Vitiligo, historical and forecasted epidemiology as well as the Vitiligo market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Vitiligo market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Vitiligo pipeline products will significantly
Benign Prostatic Hyperplasia Treatment Market 2032: FDA Approvals, Clinical trials, Therapies, Prevalence and Companies by DelveInsight | Dongkook Pharmaceutical, Urovant Sciences, Ausio Pharmaceuticals, GlaxoSmithKline, RECORDATI GROUP, Astellas Pharma,
Benign Prostatic Hyperplasia Treatment Market 2032: FDA Approvals, Clinical tria …
(Albany. USA) DelveInsight's "Benign Prostatic Hyperplasia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Benign Prostatic Hyperplasia, historical and forecasted epidemiology as well as the Benign Prostatic Hyperplasia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Benign Prostatic Hyperplasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Benign Prostatic
Leukocyte Adhesion Deficiency Treatment Market 2034: FDA Approvals, Clinical trials, Therapies, Prevalence and Companies by DelveInsight | Rocket Pharmaceuticals, Inc., Orpha Labs
Leukocyte Adhesion Deficiency Treatment Market 2034: FDA Approvals, Clinical tri …
(Albany, USA) DelveInsight's "Leukocyte Adhesion Deficiency Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Leukocyte Adhesion Deficiency, historical and forecasted epidemiology as well as the Leukocyte Adhesion Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Leukocyte Adhesion Deficiency market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore,
Staphylococcus aureus Bacteremia Treatment Market 2032: FDA Approvals, Clinical trials, Therapies, Prevalence and Companies by DelveInsight | Basilea Pharma, Armata Pharma, Destiny Pharma
Staphylococcus aureus Bacteremia Treatment Market 2032: FDA Approvals, Clinical …
(Albany, USA) DelveInsight's "Staphylococcus aureus Bacteremia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Staphylococcus aureus Bacteremia, historical and forecasted epidemiology as well as the Staphylococcus aureus Bacteremia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Staphylococcus aureus Bacteremia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore,

All 5 Releases


More Releases for Tinea

Global Onychomycosis (Tinea Unguium) Drug Market
Onychomycosis (Tinea Unguium) Drug Market Forecast 2020-2026 The Global Onychomycosis (Tinea Unguium) Drug Market research report provides and in-depth analysis on industry- and economy-wide database for business management that could potentially offer development and profitability for players in this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes
Tinea Corporis Drugs Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Tinea Corporis Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Tinea Corporis Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Tinea Corporis Drugs with respect
Tinea Pedis Treatment Market Dynamic Business Environment during 2017 - 2025
Global Tinea Pedis Treatment Market: Snapshot Athlete's foot known medically as tinea pedis, is a common skin infection of the feet caused by various kinds of fungi. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases, the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes. Apart from these areas, the fungus might develop at the
06-26-2018 | Health & Medicine
MRRSE
Tinea Pedis Treatment Market: Vesicular Tinea Pedis Disease Type Segment to Refl …
The global tinea pedis treatment market is projected to grow at a steady CAGR and surpass US$ 1.7 Bn in revenues by 2027. A new research study titled “Tinea Pedis Treatment Market: Vesicular Tinea Pedis Disease Type Segment to Reflect a High Growth Rate During the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)” added to the vast repository of Market Research Reports Search Engine
Tinea Pedis Treatment Market Key product innovations 2025
Global Tinea Pedis Treatment Market: Overview The global market for tinea pedis treatment has expanded on account of the rising awareness about skin infections and diseases amongst people. Tinea pedis, or Athlete’s foot, is a skin infection of the feet that is caused by fungus, and it results in excessive itching around the affected area. The discomfort caused by tinea pedis can become unbearable for the sufferers, and hence, it
Tinea Pedis Treatment Market Aforementioned survey till 2025
Global Tinea Pedis Treatment Market: Overview The global market for tinea pedis treatment has expanded on account of the rising awareness about skin infections and diseases amongst people. Tinea pedis, or Athlete’s foot, is a skin infection of the feet that is caused by fungus, and it results in excessive itching around the affected area. The discomfort caused by tinea pedis can become unbearable for the sufferers, and hence, it